Sadly, one Australian dies from heart disease every 12 minutes.
This is a scary statistic, particularly when many of the risk factors associated with heart disease are preventable.
Together with our Group charity Australian Heart Research, we are progressing lifesaving research into the prevention, early detection and new treatments of cardiovascular disease to better manage and beat our biggest killer.
Professor John Beltrame answers your questions about heart disease
Heart Disease Support
Investigating why some people present with ‘unexplained heart attacks’ known as myocardial infarction with non-obstructed coronary arteries (MINOCA) and examining possible mechanisms and treatments.
Funding numerous projects and clinical trials to improve care and treatments for people with Atrial Fibrillation, including testing new drugs, addressing lifestyle and sleep triggers, and providing inter-disciplinary care.
Progressed the development of the world’s smallest 3D-printed imaging catheter to identify people at high risk of a heart attack before they experience any life-threatening symptoms.
Establishing a cardiovascular biobank, which stores blood samples and other tissues long-term, to allow researchers to analyse and determine which biomarkers are responsible for particular heart disease.
Analysing the care patients with pacemakers receive when they present to a hospital emergency department to help improve future care and treatment decisions.
Identifying which patients are at risk of an emergency tear in the aorta during surgery, to then personalise their treatment and determine whether an invasive or non-invasive method is recommended to repair the damage.
Investigating whether a cancer therapy drug can be repurposed to prevent heart disease caused by Type 2 diabetes.
Analysing over 14,000 angiogram procedures to discover that the procedure works best when the catheter tube is inserted into an arm artery rather than the traditional artery in the groin.
Offering a unique follow-up clinic for women at Lyell McEwin Hospital who had a complication during pregnancy, who are now at higher risk of developing premature heart disease before the age of 55.